AIOMEGA: Transforming Health & Wellness Through AI and Biotechnology
AIOMEGA is pioneering the future of health and wellness through patented biotechnology, harnessing the power of safety focused AI-driven innovations, and cutting-edge medical devices in an IoT environment. Our flagship product, AIO BREATHE™, is 510(k) cleared, and we are poised to disrupt the sleep, cardiovascular, and athletics markets. We seek Series A funding to scale operations, expand into new markets, and drive the development of next-generation health solutions.
Why Invest in AIOMEGA?
Proven Market Traction: AIO BREATHE™ is 510(k) cleared and has demonstrated strong initial adoption. Current patients report 100% effectiveness in treating obstructive sleep apnea.
High-Growth Sectors: We are Positioned in multi-billion-dollar markets with an accelerating demand for AI-integrated, noninvasive health solutions. We don’t adapt treatments based on AI; we build new treatments with AI as the foundation.
Innovative Pipeline: AI-driven wearables, oral devices, cardiac catheters, nanotech drug delivery, IoT-AI-robotic integration (AI-RI) harnessing Predictive-AI (P-AI) Algo’s to deliver precise outcomes.
First-Mover Advantage in Sports: Our technology shows promise in reducing concussions, improving athlete safety in contact sports, and improving cardiovascular response to training.
Join the AIOMEGA Revolution
AIOMEGA is at the forefront of a healthcare revolution—bridging medicine, AI, and cutting-edge technology to improve lives. By investing in AIOMEGA, you become part of an elite movement reshaping the future of health, wellness, and performance focused on precise prediction of outcomes and safety.
View Full Page